Compugen Ltd. (CGEN)

Compugen Market Cap

Compugen has a market cap or net worth of $204.3 million as of June 30, 2026. Its market cap has increased by 34.94% in one year.

• Market Cap: 204.30M
• Enterprise Value: 72.29M
• 1-Year Change: 34.94%
• Ranking: #3898
• Category: Micro-Cap
• Stock Price: $2.16

Market Cap Chart

Since December 31, 2002, Compugen's market cap has increased from $46.50M to $204.30M, an increase of 339.36%. That is a compound annual growth rate of 6.50%.

Market Cap History

Date	Market Cap	% Change
Jun 30, 2026	204.30M	42.77%
Dec 31, 2025	143.10M	4.45%
Dec 31, 2024	137.00M	-21.58%
Dec 29, 2023	174.70M	181.77%
Dec 30, 2022	62.00M	-82.82%
Dec 31, 2021	360.80M	-64.38%
Dec 31, 2020	1.01B	183.96%
Dec 31, 2019	356.70M	220.49%
Dec 31, 2018	111.30M	-12.91%
Dec 29, 2017	127.80M	-50.45%
Dec 30, 2016	257.90M	-19.68%
Dec 31, 2015	321.10M	-5.97%
Dec 31, 2014	341.50M	4.27%
Dec 31, 2013	327.50M	91.74%
Dec 31, 2012	170.80M	1.73%
Dec 30, 2011	167.90M	3.83%
Dec 31, 2010	161.70M	16.92%
Dec 31, 2009	138.30M	1,033.61%
Dec 31, 2008	12.20M	-72.95%
Dec 31, 2007	45.10M	-37.45%
Dec 29, 2006	72.10M	-38.95%
Dec 30, 2005	118.10M	-14.61%
Dec 31, 2004	138.30M	4.38%
Dec 31, 2003	132.50M	184.95%
Dec 31, 2002	46.50M	-

View and export this data all the way back to 2002. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jun 29, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jun 30, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Voyager Therapeutics	211.47M
Codexis	209.97M
Precision BioSciences	208.74M
Immunic	208.41M
Cellectis	206.13M
Equillium	205.49M
Turn Therapeutics	204.05M
Tonix Pharmaceuticals Holding	202.93M